Pediatric hemophagocytic syndromes: A diagnostic and therapeutic challenge

Allergy, Asthma and Clinical Immunology

Volumn 1, Issue 4, 2005, Pages 142-160

  Jabado, Nada ^a   McCusker, Christine ^a   De Saint Basile, Genevieve ^b  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CIDOFOVIR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; RIBAVIRIN; STEROID; THYMOCYTE ANTIBODY;

BONE MARROW BIOPSY; CELL DEATH; CHEDIAK HIGASHI SYNDROME; CLINICAL FEATURE; DISEASE ASSOCIATION; GRISCELLI SYNDROME; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEMOPHAGOCYTIC SYNDROME; HISTOPATHOLOGY; HUMAN; INFECTION; LIVER BIOPSY; LUMBAR PUNCTURE; MORTALITY; NATURAL KILLER CELL; NEEDLE BIOPSY; PATIENT CARE; REVIEW; RHEUMATIC DISEASE; SPLEEN BIOPSY; STEM CELL TRANSPLANTATION;

EID: 33748551304     PISSN: 17101484     EISSN: None     Source Type: Journal    
DOI: 10.2310/7480.2005.00027     Document Type: Review

References (99)

1. Scott R, Robb-Smith A. Histiocytic medullary reticulosis. Lancet 1939;2:194-8.
2. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:29-33.
3. Henter JI, Blinder G. Familial hemophagocytic lymphohistiocytosis. Clinical review based on the findings in seven children. Acta Paediatr Scand 1991;80:269-77.
4. Mouy R, Stephan JL, Pillet P, et al. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 1996;129:750-4.
5. Stephan JL, Zeller J, Hubert P, et al. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 1993;11:451-6.
6. Wong KF, Hui PK, Chan JK, et al. The acute lupus hemophagocytic syndrome. Ann Intern Med 1991;114:387-90.
7. Kadin ME, Kamoun M, Lamberg J. Erythrophagocytic T gamma lymphoma: a clinicopathologic entity resembling malignant histiocytosis. N Engl J Med 1981;304:648-53.
8. Henter JI, Ehrnst A, Andersson J, Blinder G. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr 1993;82:369-72.
9. Browett PJ, Varcoe AR, Fraser AG, Ellis-Pegler RB. Disseminated tuberculosis complicated by the hemophagocytic syndrome. Aust NZJ Med 1988;18:79-80.
10. Caksen H, Akbayram S, Oner AF, et al. A case of typhoid fever associated with hemophagocytic syndrome. J Emerg Med 2003;25:321-2.
11. Campo E, Condom E, Miro MJ, et al. Tuberculosis-associated hemophagocytic syndrome. A systemic process. Cancer 1986;58:2640-5.
12. Matzner Y, Behar A, Been E, et al. Systemic leishmaniasis mimicking malignant histiocytosis. Cancer 1979;43:398-402.
13. de Saint Basile G, Fischer A. Defective cyto-toxic granule-mediated cell death pathway impairs T lymphocyte homeostasis. Curr Opin Rheumatol 2003;15:436-45.
14. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998;280:243-8.
15. Zinkernagel RM. Localization dose and time of antigens determine immune reactivity. Semin Immunol 2000;12:163-71, 257-344.
16. Haddad E, Sulis ML, Jabado N, et al. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 1997;89:794-800.
17. Henter JI, Elinder G. Cerebromeningeal haemophagocytic lymphohistiocytosis. Lancet 1992;339:104-7.
18. Henter JI, Nennesmo I. Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr 1997;130:358-65.
19. Henter JI, Elinder G, Soder O, et al. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991;78:2918-22.
20. Takada H, Ohga S, Mizuno Y, et al. Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol 1999;106:182-9.
21. Hasegawa D, Kojima S, Tatsumi E, et al. Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood 1998;91:2793-9.
22. Stepp SE, Mathew PA, Bennett M, et al. Perform: more than just an effector molecule. Immunol Today 2000;21:254-6.
23. de Saint Basile G, Fischer A. The role of cytotoxicity in lymphocyte homeostasis. Curr Opin Immunol 2001;13:549-54.
24. Stinchcombe J, Bossi G, Griffiths GM. Linking albinism and immunity: the secrets of secretory lysosomes. Science 2004;305:55-9.
25. Lay JD, Tsao CJ, Chen JY, et al. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997;100:1969-79.
26. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000;6:601-8.
27. Schneider EM, Lorenz I, Muller-Rosenberger M, et al. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood 2002;100:2891-8.
28. Egeler RM, Shapiro R, Loechelt B, Filipovich A. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 1996;18:340-5.
29. Farquhar J, Claireaux A. Familial haemophagocytic reticulosis. Arch Dis Child 1952;27:519-25.
30. Henter JI, Blinder G, Soder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Acta Paediatr Scand 1991;80:428-35.
31. Dufourcq-Lagelouse R, Pastural E, Barrat FJ, et al. Genetic basis of hemophagocytic lymphohistiocytosis syndrome. Int J Mol Med 1999;4:127-33.
32. Feldmann J, Le Deist F, Ouachee-Chardin M, et al. Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol 2002;117:965-72.
33. Jabado N, de Graeff-Meeder ER, Cavazzana-Calvo M, et al. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood 1997;90:4743-8.
34. Ohadi M, Lalloz MR, Sham P, et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet 1999;64:165-71.
35. Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003;115:461-73.
36. Dufourcq-Lagelouse R, Jabado N, Le Deist F, et al. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity. Am J Hum Genet 1999;64:172-9.
37. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999;286:1957-9.
38. Kogawa K, Lee SM, Villanueva J, et al. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 2002;99:61-6.
39. Feldmann J, Le Deist F, Fischer A, de Saint Basile G. [Munc13-4 is essential for cytolytic granule fusion]. Med Sci (Paris) 2004;20:144-6.
40. Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003;115:461-73.
41. Beguez-Cesar A. Neutropenia cronica maligna familiar con granulaciones atipicas de los leucocitos. Bol Soc Cubana Pediatr 1943:900-22.
42. Chediak M, Chediak B, Fleites O, Hernandez A. [Presentation of a case of Cooley's anemia in a Cuban boy; first report in Cuba.]. Bol Liga Contra Cancer Havana 1952;27:20-6.
43. Chediak MM. [New leukocyte anomaly of constitutional and familial character.]. Rev Hematol 1952;7:362-7.
44. Higashi O. Congenital abnormity of peroxidase granules; a case of congenital gigantism of peroxidase granules, preliminary report. Tohoku J Exp Med 1953;58:246.
45. Barbosa MD, Nguyen QA, Tchernev VT, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 1996;382:262-5.
46. Nagle DL, Karim AM, Woolf EA, et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nature Genet 1996;14:307-11.
47. Certain S, Barrat F, Pastural E, et al. Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome. Blood 2000;95:979-83.
48. Karim MA, Suzuki K, Fukai K, et al. Apparent genotype-phenotype correlation in childhood, adolescent, and adult Chediak-Higashi syndrome. Am J Med Genet 2002;108:16-22.
49. Ward DM, Griffiths GM, Stinchcombe JC, Kaplan J. Analysis of the lysosomal storage disease Chediak-Higashi syndrome. Traffic 2000;1:816-22.
50. Tchernev VT, Mansfield TA, Giot L, et al. The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins. Mol Med 2002;8:56-64.
51. Tardieu M, Lacroix C, Neven B, et al. Progressive neurological dysfunctions twenty years after allogeneic bone-marrow transplantation for Chediak-Higashi syndrome. Blood 2005;106:40-2.
52. Griscelli C, Durandy A, Guy-Grand D, et al. A syndrome associating partial albinism and immunodeficiency. Am J Med 1978;65:691-702.
53. Klein C, Philippe N, Le Deist F, et al. Partial albinism with immunodeficiency (Griscelli syndrome). J Pediatr 1994;125(6 Pt 1):886-95.
54. Pastural E, Barrat FJ, Dufourcq-Lagelouse R, et al. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet 1997;16:289-92.
55. Menasche G, Pastural E, Feldmann J, et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 2000;25:173-6.
56. Menasche G, Ho CH, Sanal O, et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest 2003;112:450-6.
57. Purtilo DT, Cassel CK, Yang JP, Harper R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1975;1:935-40.
58. Chen R, Relouzat F, Roncagalli R, et al. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors. Mol Cell Biol 2004;24:5144-56.
59. Engel P, Eck MJ, Terhorst C. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat Rev Immunol 2003;3:813-21.
60. Chan B, Lanyi A, Song HK, et al. SAP couples Fyn to SLAM immune receptors. Nat Cell Biol 2003;5:155-60.
61. Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19:197-223.
62. Parolini S, Bottino C, Falco M, et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med 2000;192:337-46.
63. Tangye SG, Cherwinski H, Lanier LL, Phillips JH. 2B4-mediated activation of human natural killer cells. Mol Immunol 2000;37:493-501.
64. Tangye SG, Phillips JH, Lanier LL, Nichols KE. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J Immunol 2000;165:2932-6.
65. Silverman ED, Miller JJ 3rd, Bernstein B, Shafai T. Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis. J Pediatr 1983;103:872-6.
66. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 1985;106:561-6.
67. Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol 2003;15:587-90.
68. Grom AA, Villanueva J, Lee S, et al. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003;142:292-6.
69. Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum 2004;50:689-98.
70. + T cells in patients with systemic onset juvenile rheumatoid arthritis [abstract]. Arthritis Rheum 2000;Suppl:S472.
71. Takei M, Ishiwata T, Mitamura K, et al. Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis. Int Immunol 2001;13:559-65.
72. Risdall RJ, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979;44:993-1002.
73. Abdelkefi A, Ben Othman T, Torjman L, et al. Plasmodium falciparum causing hemophagocytic syndrome after allogeneic blood stem cell transplantation. Hematol J 2004;5:449-50.
74. Albrecht H, Schafer H, Stellbrink HJ, Greten H. Epstein-Barr virus-associated hemophagocytic syndrome. A cause of fever of unknown origin in human immunodeficiency virus infection. Arch Pathol Lab Med 1997;121:853-8.
75. Auerbach M, Haubenstock A, Soloman G. Systemic babesiosis. Another cause of the hemophagocytic syndrome. Am J Med 1986;80:301-3.
76. Babu TG, Boctor D, Davey A, et al. Cytomegalovirus-associated hemophagocytic syndrome in a child with Crohn disease receiving azathioprine. J Pediatr Gastroenterol Nutr 2004;39:418-21.
77. Banno S, Matsumoto Y, Sugiura Y, Ueda R. [Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report]. Ryumachi 1997;37:581-6.
78. Baraldes MA, Domingo P, Gonzalez MJ, et al. Tuberculosis-associated hemophagocytic syndrome in patients with acquired immunodeficiency syndrome. Arch Intern Med 1998;158:194-5.
79. Bell MD, Wright RK. Fatal virus-associated hemophagocytic syndrome in a young adult producing nontraumatic splenic rupture. J Forensic Sci 1992;37:1407-17.
80. Bird G, Peel D, McCarthy K, Williams H. Epstein-Barr virus induced virus-associated hemophagocytic syndrome and monoclonal TCR-beta rearrangement: a case report. Hematol Oncol 1997;15:47-52.
81. Blanche P, Robert F, Dupouy-Camet J, Sicard D. Toxoplasmosis-associated hemophagocytic syndrome in a patient with AIDS: diagnosis by the polymerase chain reaction. Clin Infect Dis 1994;19:989-90.
82. Boruchoff SE, Woda BA, Pihan GA, et al. Parvovirus B19-associated hemophagocytic syndrome. Arch Intern Med 1990;150:897-9.
83. Cantero-Hinojosa J, Diez-Ruiz A, Santos-Perez JL et al. Lyme disease associated with hemophagocytic syndrome. Clin Investig 1993;71:620.
84. Chim CS, Fong CY, Ma SK, et al. Reactive hemophagocytic syndrome associated with Penicillium marneffei infection. Am J Med 1998;104:196-7.
85. Chien YH, Lee PI, Huang LM, et al. Typhoid fever presenting as infection-associated hemophagocytic syndrome: report of one case. Acta Paediatr Taiwan 1999;40:339-40.
86. Chien CC, Chiou TJ, Lee MY, et al. Tuberculosis-associated hemophagocytic syndrome in a hemodialysis patient with protracted fever. Int J Hematol 2004;79:334-6.
87. Real E, Gomez A, Alcaraz MJ, et al. Fulminant hemophagocytic syndrome as presenting feature of T-cell lymphoma and Epstein-Barr virus infection. Haematologica 2000;85:439-40.
88. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002;14:548-52.
89. Takasaki N, Kaneko Y, Maseki N, et al. Hemophagocytic syndrome complicating T-cell acute lymphoblastic leukemia with a novel t(11;14)(p15;q11) chromosome translocation. Cancer 1987;59:424-8.
90. Janka G, Imashuku S, Elinder G, et al. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:435-44.
91. Su IJ, Hsu YH, Lin MT, et al. Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 1993;72:2019-27.
92. Su IJ, Wang CH, Cheng AL, Chen RL. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymphoma 1995;19:401-6.
93. Lay JD, Chuang SE, Rowe M, Su IJ. Epstein-Barr virus latent membrane protein-1 mediates upregulation of tumor necrosis factor-alpha in EBV-infected T cells: implications for the pathogenesis of hemophagocytic syndrome. J Biomed Sci 2003;10:146-55.
94. Kawaguchi H, Miyashita T, Herbst H, et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 1993;92:1444-50.
95. Craig FE, Clare CN, Sklar JL, Banks PM. T-cell lymphoma and the virus-associated hemophagocytic syndrome. Am J Clin Pathol 1992;97:189-94.
96. Henter JI, Arico M, Egeler RM, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 1997;28:342-7.
97. Caillat-Zucman S, Le Deist F, Haddad E, et al. Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: a single-center comparative analysis of genoidentical, haploidentical or unrelated donors. Bone Marrow Transplant 2004;33:1089-95.
98. Arico M, Janka G, Fischer A, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 1996;10:197-203.
99. Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996;128:275-8.